The aim of this study is to evaluate the safety and efficacy of balloon expandable covered stenting of access complications, stenoses or pseudoaneurysms of the common femoral access.
In the past decades, there has been a paradigm shift in the field of vascular surgery, with endovascular interventions replacing traditional open surgical procedures on an increasing scale. Most of these interventions are performed via the femoral artery. Even with modern percutaneous vascular closure devices, interventional laboratories report a high incidence of vascular complications, most commonly bleeding. Interventional procedures are gaining ground as an alternative to surgery. Having regard to the fact that femoral arteries are in constant motion due to their location and are subject to intense bending forces, the long-term durability of stents has been questioned in the absence of long-term follow-up data. There is currently no broad consensus on the strategy of care for vascular complications, and overall the decision is left to the discretion of the interventionalist, largely determined by the available local resources and infrastructure. The use of covered stents is an option for endovascular treatment of the complications: the self expanding nitinol framed stent graft with polytetrafluoroethylene (PTFE) coating and the cobalt-chrome framed, also PTFE coated balloon expandable stent. The main aim of this research is to analyse the short- and long-term outcome of these alternatives.
Study Type
OBSERVATIONAL
Enrollment
24
University of Szeged, Albert Szent-Györgyi Health Center, Second Department of Medicine and Cardiology Centre
Szeged, Csongrád-Csanád, Hungary
Gottsegen National Cardiovascular Center
Budapest, Hungary
Semmelweis University Heart and Vascular Center
Budapest, Hungary
Primary patency rate
Number of patent common femoral arteries at one year
Time frame: 1 year
Reintervention rate
Number of reinterventions on the treated vessels
Time frame: 1 year
Amputation rate
Number of amputations at the side of the treated common femoral artery
Time frame: 1 year
Restenosis rate
Number of significant (peak systolic velocity ratio \> 2,4) restenoses found at one year
Time frame: 1 year
Walking disturbance rate
Number of any new onset walking impairment
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.